Charlotte's Web Holdings (CWBHF) Total Non-Current Liabilities (2020 - 2026)
Charlotte's Web Holdings (CWBHF) reported Total Non-Current Liabilities of $77.6 million for Q1 2026, up 13.37% year-over-year from $68.5 million in Q1 2025, and up 13.07% quarter-over-quarter from $68.7 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 7 years of Total Non-Current Liabilities data on file, last reported at $77.6 million in Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at $77.6 million, up 13.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $77.6 million (up 13.37% YoY), and the FY2025 annual result was $68.7 million, down 2.51% from the prior year.
- Total Non-Current Liabilities improved to $77.6 million in Q1 2026 per CWBHF's latest filing, from $68.7 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $94.0 million in Q2 2024 and troughed at $31.7 million in Q3 2022.
- A 5-year average of $64.9 million and a median of $70.4 million in 2024 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2025 and 2026: Total Non-Current Liabilities slipped 22.26% in 2025, then climbed 13.37% in 2026.
- A 5-year view of Total Non-Current Liabilities shows it stood at $31.7 million in 2022, then surged by 131.71% to $73.3 million in 2023, then slipped by 3.99% to $70.4 million in 2024, then fell by 2.51% to $68.7 million in 2025, then grew by 13.07% to $77.6 million in 2026.
- Business Quant data shows CWBHF's Total Non-Current Liabilities at $77.6 million in Q1 2026, $68.7 million in Q4 2025, and $63.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 18.28 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 11.64 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 44.12 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.24 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.26 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.44 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.81 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.13 Bn |
| 10 | Charlotte's Web Holdings | - | - | 5.20 Mn | 77.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77.63 Mn |
| Dec 31, 2025 | 68.65 Mn |
| Sep 30, 2025 | 63.48 Mn |
| Jun 30, 2025 | 73.05 Mn |
| Mar 31, 2025 | 68.47 Mn |
| Dec 31, 2024 | 70.42 Mn |
| Sep 30, 2024 | 72.92 Mn |
| Jun 30, 2024 | 93.97 Mn |
| Mar 31, 2024 | 75.48 Mn |
| Dec 31, 2023 | 73.34 Mn |
| Sep 30, 2022 | 31.65 Mn |
| Jun 30, 2022 | 37.09 Mn |
| Mar 31, 2022 | 37.66 Mn |
| Dec 31, 2021 | 41.06 Mn |
| Dec 31, 2020 | 52.24 Mn |